Catalyst Wire Dossier Catalyst Wire Dossier

Adenovirus-vectored intranasal influenza vaccine (H5N1)

Adenovirus-vectored intranasal influenza vaccine · Altimmune, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus-vectored intranasal influenza vaccine (H5N1), covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine. [Phase 1]

See pricing